Position in PGEN
as of Jun 30, 2026
· filed Aug 27, 2026
Position Value
$1,902,660
-$1,623,707 QoQ
Shares Held
333,800
-63.4% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 210 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $248,190,588 across 122 Biotechnology names. PGEN ranks #33 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
103,755 | $51,538,220 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
196,661 | $15,593,250 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
187,166 | $14,649,482 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
30,558 | $11,357,491 | |
| 5 | TECH |
BIO-TECHNE Corp
|
119,590 | $8,449,033 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,473 | $7,777,414 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,969 | $7,215,387 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
176,956 | $6,584,532 |
All Filings in PGEN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,902,660 | 333,800 | Shares | Sole | 2026-08-27 | |
| 2026-03-31 | $3,526,367 | 911,206 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,804,547 | 431,710 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $2,624,008 | 797,571 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,014,861 | 714,691 | Shares | Sole | 2025-09-26 | |
| 2025-03-31 | $1,064,889 | 714,691 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $687,647 | 613,971 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $584,222 | 614,971 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||